Age-associated insulin resistance (IR) and obesity-associated IR are two physiologically distinct forms of adult onset diabetes. While macrophage-driven inflammation is a core driver of obesityassociated IR 1 -6 , the underlying mechanisms of the obesity-independent yet highly prevalent ageassociated IR 7 are largely unexplored. Comparative adipo-immune profiling (AIP) reveals that fatresident regulatory T cells, termed fTregs, accumulate in adipose tissue as a function of age, but not obesity. Supporting the existence of two distinct mechanisms underlying IR, mice deficient in fTregs are protected against age-associated IR, yet remain susceptible to obesity-associated IR and metabolic disease. In contrast, selective depletion of fTregs via anti-ST2 antibody treatment increases adipose tissue insulin sensitivity. These findings establish that distinct immune cell populations within adipose tissue underlie aging-and obesity-associated IR and implicate fTregs as adipo-immune drivers and potential therapeutic targets in the treatment of age-associated IR.
immune cell components of adipose depots using a flow cytometry approach termed adipoimmune profiling (AIP) (Extended Data Fig. 1b-d , Extended Data Table 1 ). In contrast to the decrease in anti-inflammatory M2 adipose tissue macrophages (ATMs) and eosinophils observed in obesity-driven IR, AIP revealed that these cell populations are largely unperturbed in visceral adipose tissue (VAT) from aged mice (M2 ATMs -aged: 33.6 ± 3.8%, young: 29.8 ± 4.1%, obese: 22.9 ± 6.3%; eosinophils -aged: 4.4% ± 1.6%, young: 4.7% ± 0.7%, obese: 0.8% ± 1.0%, Fig. 1a ) 8 -12 . Rather, the relative portion of the nonmacrophage compartment is significantly increased in aged compared to young or obese mice (aged: 24.3 ± 4.6%, young: 17.9 ± 2.8%, obese 15.7 ± 3.8%, Fig. 1a ), which is largely attributable to a ~12 fold expansion in the fat-resident regulatory T cell (fTreg) population (aged: 5.0 ± 1.2%, young: 0.4 ± 0.1%, obese: 0.1 ±0.1%, Fig. 1a ,b) 13 , 14 . These conditiondependent AIP signatures of adipose tissue suggest that distinct pathophysiologic processes drive age-and obesity-associated IR and specifically implicate fTregs in age-associated IR.
Tregs in the fat express Pparγ at a high level, which allows them to expand their relative numbers approximately 6-7 fold 15 . Knockout of Pparγ in Tregs blocks this accumulation. Intriguingly, the selective loss of fTregs attenuates many of the hallmarks of age-associated metabolic dysregulation 16 . They weigh less than control mice and are leaner (decreased VAT and SAT adiposity) despite increased food consumption ( Fig. 2b-d ). In addition, the respiratory exchange ratio (RER, Fig. 2e ), oxygen consumption ( Fig. 2f) , and core body temperature ( Fig. 2g ) are increased in aged fTreg KO mice relative to control mice. These marked improvements suggest that the age-associated metabolic phenotype is closely linked with VAT immune responses, and that in the aged setting, a reduction in fTreg numbers may be protective. Indeed, the AIPs of aged fTreg KO mice are shifted towards those of young mice, as visualized by principal component analysis (Fig. 2h) .
Although the fTreg KO phenotype is most pronounced in aged mice, a reduction in fTreg levels can also be found in obese fTreg KO mice (Fig. 3a) . However, the beneficial metabolic effects of fTreg ablation are only significant in age-associated metabolic dysregulation where fasting serum glucose and insulin levels are significantly reduced (Fig.  3b ,c, Extended Data Fig. 4a ). Furthermore, aged fTreg KO mice display smaller glucose excursions during glucose tolerance tests (GTTs) and increased sensitivity during insulin tolerance tests (ITTs) compared to weight-matched control mice (Fig. 3e) . Again, these improvements in glucose homeostasis are observed only in aged mice; no significant differences are seen in young or obese fTreg KO mice (Fig. 3d,f) , which is consistent with the largely unchanged AIP of obese fTreg KO mice (Extended Data Fig. 5a ,b).
While fTregs were previously implicated in the insulin-sensitizing function of the PPARγ agonists thiazolidinediones (TZDs) 15 , in our studies fTreg KO mice display similar metabolic improvements to the TZD rosiglitazone (Rosi) as control mice. These beneficial effects of TZDs are evident with either direct treatment of obese mice (therapeutic intervention; Extended Data Fig. 6a-g ) or prophylactic treatment (drug intervention coincident with HFD-feeding, Extended Data Fig. 6h-l) . Additionally, we find that the insulin-sensitizing effects of Rosi precede the TZD-induced expansion of fTregs in HFD-fed mice (Extended Data Fig. 6m-q) . While intercolony variation cannot be ruled out, our findings do not support a significant role for fTregs in the therapeutic mechanism of action of TZDs.
Histologically, aged fTreg KO VAT depots appear similar to control mice, and inflammatory processes such as macrophage crowning are observed at comparable frequencies (Fig. 3g , data not shown). However, aged fTreg KO VAT has increased levels of TNFα (Extended Data Fig. 7a ), increased expression of Vegfa (implicated in adipose remodeling and insulin sensitivity 17 , Extended Data Fig. 7b ), and decreased expression of extracellular matrix genes (including collagen VI implicated in adipose tissue rigidity 18 , and the wound response gene Sparc, Extended Data Fig. 7b ,c) compared to control tissue. Accompanying these changes, multiple proteases involved in ECM remodeling and angiogenesis (members of the ADAM, ADAMTS, MMP, and CELA families) are differentially expressed (Extended Data Fig.  7b,d ). Of note, adipocytes from aged fTreg KO mice are smaller than those in control mice (fTreg KO: ~70% <5,000 μm 2 , control: ~41% <5,000 μm 2 , Fig. 3h , Extended Data Fig. 4b ), and serum non-esterified free fatty acid (NEFA) levels are reduced to almost half those of control mice; both indicators of improved insulin sensitivity (Fig. 3i ). In addition, circulating levels of the adipokine resistin, which positively correlates with murine insulin resistance, are reduced in the aged fTreg KO mice (Fig. 3j ) 19 , 20 . Furthermore, aged fTreg KO mice present with decreased hepatic steatosis, as determined histologically and by decreased fasting hepatic and serum triglyceride content ( Fig. 3l-n) . In combination, these findings suggest that the loss of fTregs in adipose tissue alleviates many of the indications of ageassociated IR in mice, a primary clinical manifestation of metabolic aging.
To more directly associate fTregs with age-associated IR, we measured basal glucose uptake in adipose tissue ex vivo. Notably, VAT from fTreg KO mice took up almost twice the amount of glucose as control tissue (Fig. 3k) . Conversely, expansion of fTregs in WT mice via treatment with IL-2/IL-2 mAb complex treatment 21 abrogates basal glucose uptake in VAT by ~50% (Fig. 3o,p) . This inverse correlation between fTreg numbers and glucose uptake in adipose tissue supports a causal association between fTregs and IR during aging. (Fig. 4b) . Importantly, aged fTregs maintain their suppressive functionality as measured by in vitro suppression assays (Fig. 4c,d) , and indicated by the high expression levels of Ctla4 25 , Il2ra 26 , and the anti-inflammatory cytokine Il10 (Fig. 4b) . We posit that the transcriptional differences between fTregs and splenic Tregs (found in the fTreg cluster of 1049 genes) may provide a therapeutic avenue to selectively manipulate fTreg populations. The IL-33 receptor ST2, which lies within the fTreg cluster, has been recently implicated in effector Treg and in particular fTreg development 27 , 28 . Indeed, ST2 was ~60
and ~30 times more highly expressed in fTregs compared to splenic Tregs and fat Tconv cells, respectively, consistent with the ImmGen database (http://www.immgen.org), (Fig. 4e , Extended Data Fig. 8b ). Flow cytometry confirmed that ST2 is expressed on the cell surface of the majority of fTregs, but on relatively few fat Tconv, or splenic Treg or Tconv cells (Fig.  4f,g ). Furthermore, VAT has ~25x more ST2 + fTregs than ST2 + fat Tconv; a similarly trending ~10x difference is observed in the spleen (Fig. 4h ).
To explore the therapeutic potential of the IL-33/ST2 signaling pathway, aged mice were initially injected with IL-33 (0.5 μg i.p. on days 0, 2, 4, analysis on day 6) to expand the fTreg population ( Fig. 4i-k ). In agreement with fTreg expansion driven by IL2/anti-IL2 treatment, mice injected with IL-33 display signs of IR (basal glucose uptake in VAT reduced to ~60% of control mice, Fig. 4l ). In the converse approach, acute treatment with an anti-ST2 antibody (200 μg/mouse i.p. on days 0 and 2, analysis on day 3) is able to significantly deplete fTregs (~50% reduction), with a smaller percentage reduction of splenic Tregs (Fig. 4m) . Importantly, the partial depletion of fTregs achieved with acute anti-ST2 treatment coincides with an increase in insulin-stimulated glucose uptake in VAT (~25% increase in glucose uptake compared to control treated mice, Fig. 4n ), suggesting a link between fTreg depletion and increased adipose insulin sensitivity. Furthermore, this increase in insulin sensitivity is achieved without any signs of Tconv cell activation associated with systemic Treg dysfunction (Extended Data Fig. 8c -e).
As obesity and aging often associate in man, we challenged aged fTreg KO and control mice with HFD. While initially protected against HFD-induced weight gain and associated metabolic dysregulation, the metabolic benefits attributed to the loss of fTregs were progressively lost over 8 weeks (Extended Data Fig. 9a -e), further suggesting distinct pathophysiologies drive obesity-versus age-associated IR.
Taken together, our data provide evidence that distinct adipo-immune populations orchestrate unique features of age-and obesity-associated IR. We show in the non-obese setting that Pparγ-positive fTregs accumulate to unusually high levels (6.7%) as a function of age, exacerbating both the decline of adipose metabolic function as well as the rise in insulin resistance ( Fig. 4o) . These results are in marked contrast to the increased role of M1 ATMs in metabolic dysfunction linked to obesity, coupled with a suppression of fTreg levels to 0.9%. Thus, these studies highlight contrasting roles of the immune compartment in contributing to key aspects of adipose health and disease.
Given the classical immune suppressive and anti-inflammatory nature of Tregs, we speculate that the chronic inflammatory processes that drive obesity-associated IR seem unlikely to be driving age-associated IR. Indeed, there is increasing appreciation that maintaining a certain degree of inflammation is beneficial for adipose tissue remodeling and its metabolic function 29 . Failure to preserve an optimal immune state in the aged adipose tissue may directly contribute to metabolic disorders such as insulin resistance and age-associated diabetes. We suggest Type IV diabetes as a designation for non-obese dependent fTreg driven metabolic disease of the elderly.
In this context, it is of particular significance that fTregs in aged adipose tissue express the cytokine receptor ST2 at ~30-60 fold higher levels than in other sites such as spleen, making the fTreg population sensitive to depletion via anti-ST2 treatment. While ST2 has been implicated in other physiological processes and immune cell types that may also impact glucose homeostasis, this simple fTreg depletion approach increases adipose tissue insulin sensitivity suggesting the potential of selective fTreg depletion therapy in the prevention of age-related insulin resistance.
Methods
Full Methods and associated references are available in the online version of the paper at www.nature.com/nature.
Online Methods

Mice
All mice were housed in the specific pathogen-free facilities at The Salk Institute for Biological Studies or purchased from Taconic Biosciences. C57BL/6NTac mice were purchased from Taconic Biosciences for comparative adipo-immune profiling (AIP). Agematched retired breeders were purchased for AIP of aged adipose tissue, and diet-induced obese C57BL/6NTac mice were purchased for profiling of obese adipose tissue. fTreg KO mice were generated by crossing Foxp3 YFP/cre (30) and Pparg floxed (31) 
Adipo-immune profiling (AIP)
Visceral (epididymal) and subcutaneous (inguinal) adipose depots were dissected from mice after 10mL PBS perfusion through the left ventricle. Inguinal lymph nodes resident in inguinal adipose tissue were removed. Adipose tissue was minced into fine pieces (2-5mm 3 ) and digested in stromal vascular isolation buffer (100mM HEPES pH7.4, 120mM NaCl, 50mM KCl, 5mM glucose, 1mM CaCl2, 1.5% BSA) containing 1mg/ml collagenase at 37°C with intermittent shaking for 1.5 hours. The suspension was then passed through a 100 μm mesh to remove undigested clumps and debris. The flowthrough was allowed to stand for 10 min to separate the floating adipocyte fraction and infranatant containing the stromal vascular fraction. The infranatant was removed while minimally disturbing the floating adipocyte fraction and centrifuged at 400g for 10 minutes. The pellet containing the stromal vascular fraction was washed once in 10mL RPMI. The resultant isolated cells were subjected to FACS analysis. The following antibodies were used to assemble the adipoimmune profile: BioLegend -CD45. 
Body composition and adipocyte size analyses
Body composition was measured with an Echo MRI-100 body composition analyzer (Echo Medical Systems). VAT (epididymal) was dissected, and the wet weight was determined. Adipose tissues were fixed in 10% formalin, sectioned, and stained in hematoxylin and eosin. An adipocyte cross-sectional area was determined from photomicrographs of VAT using ImageJ.
In vivo metabolic phenotype analysis
Real-time metabolic analyses were conducted in a Comprehensive Lab Animal Monitoring System (Columbus Instruments). CO 2 production, O 2 consumption, and ambulatory counts were determined for at least three consecutive days and nights after at least 24 h for adaptation before data recording.
Principal component analysis (PCA) of AIP
Non-macrophage immune cell populations, described as percentage of the total CD45.2 + immune compartment, were inputted into MetaboAnalyst 3.0 (http://www.metaboanalyst.ca/ MetaboAnalyst/) for PCA. No normalizations, transformations, or scalings were implemented.
Glucose homeostasis studies
Fasting was induced for 6 h, except for GTTs, which were conducted after overnight fasting. Glucose (1-2 g/kg, i.p.) and insulin (0.5-1.0 U/kg, i.p.) was injected for GTTs and ITTs, respectively. Blood glucose was monitored using a Nova Max Plus glucometer.
Histological analyses
Sections (4 μm) of fixed tissues were stained with haematoxylin and eosin according to standard procedures. Histopathological scores were graded on blinded samples for severity and extent of inflammation and morphological changes by a pathologist.
Serum analyses
Blood was collected by tail bleeding or right atrial puncture. Non-esterified fatty acids (Wako) and triglycerides (Thermo) were measured using colorimetric methods. Serum insulin levels (Ultra Sensitive Insulin, Crystal Chem) were measured by ELISAs. Serum cytokine and metabolic hormone levels were analyzed by the Luminex Bio-Plex system using the Mouse Cytokine 23-Plex Panel and Diabetes Panel, respectively, as according to the manufacturer's instructions (Bio-Rad).
Core body temperature
Mice were single housed, and core body temperature was measured with a clinical rectal thermometer (Thermalert model TH-5; Physitemp) during the middle of the light cycle. The probe was dipped in a room temperature lubricating glycerol before insertion.
Ex vivo 2-DG uptake assays
Adipose tissue was dissected from mouse, cut into small pieces with scissors, washed and incubated for 30 min with Krebs-Ringer Bicarbonate HEPES buffer (KRBH, 120 mM NaCl, 4 mM KH 2 PO 4 , 1 mM MgSO 4 , 0.75 mM CaCl 2 , 30 mM Hepes, 10 mM NaHCO 3 , pH 7.4, supplemented with 1% fatty-acid free BSA). For determination of exogenous insulinstimulated 2-deoxy-D-glucose (2-DG) uptake, adipose was incubated in KRBH with 100-200nM insulin for 20 mins in 37 °C. Cold 2-DG and hot 2-DG-1,2-3 H(N) was added to incubated adipose tissue such that the final concentration of cold 2-DG was 0.1 mM and final quantity of hot 2-DG-1,2-3 H(N) was 0.1 μCi (assuming total reaction volume ~400 uL). Adipose was further incubated 20 mins in 37 °C, then washed three times with PBS before being lysed by scintillation fluid. 2-DG uptake was determined by measuring scintillation counts normalized to adipose tissue mass utilized for assay. Non-specific 2-DG uptake levels were determined by co-treating adipose tissue with cytochalasin B (0.1 μM final concentration) with the addition of cold and hot 2-DG.
IL-2-anti-IL-2 complex and IL-33 injections
IL-2-anti-IL-2 complexes were prepared by incubating 2 μg of murine IL-2 (Biolegend) with 10 μg of anti-IL-2 antibody (JES6.1, Bioxcell) in a total volume of 200 μL of PBS for 30 min at 37°C (amounts given per injection). Mice were injected i.p. three times (days 0,1, 2) and analyzed on day 8. For IL-33 expansion assays, mice were injected i.p. with 0.5 μg of recombinant murine IL-33 in PBS (R&D systems) three times (days 0, 2, 4) and analyzed on day 6. PBS was used for control injections.
RNA-Seq library generation
Total RNA was isolated from sorted cells or whole tissues using TRIzol reagent (Invitrogen) as per the manufacturer's instructions and treated with DNaseI (Qiagen) for 30 min at 22 °C. Sequencing libraries were prepared from 10-100 ng of total RNA using the TruSeq RNA sample preparation kit v2 (Illumina) according to the manufacturer's protocol. Briefly, mRNA was purified, fragmented and used for first-and second-strand cDNA synthesis followed by adenylation of 3′ ends. Samples were ligated to unique adaptors and subjected to PCR amplification. Libraries were then validated using the 2100 BioAnalyzer (Agilent), normalized and pooled for sequencing. RNA-Seq libraries prepared from two biological replicates for each experimental condition were sequenced on the Illumina HiSeq 2500 using barcoded multiplexing and a 100-bp read length.
High-throughput sequencing and analysis
Image analysis and base calling were done with Illumina CASAVA-1.8.2. This yielded a median of 29.9M usable reads per sample. Short read sequences were mapped to a UCSC mm9 reference sequence using the RNA-Seq aligner STAR 33 . Known splice junctions from mm9 were supplied to the aligner and de novo junction discovery was also permitted. Differential gene expression analysis, statistical testing and annotation were performed using Cuffdiff 2 34 . Transcript expression was calculated as gene-level relative abundance in fragments per kilobase of exon model per million mapped fragments and employed correction for transcript abundance bias 35 . RNA-Seq results for genes of interest were also explored visually using the UCSC Genome Browser.
Hierarchical clustering
Differentially expressed gene names and corresponding FPKM values across samples were inputted into GENE-E (Broad Institute) for hierarchical clustering analysis (implemented one minus pearson correlation for sample and gene distance metrics and the average linkage method) and visualization. Gene cluster names were created to describe the gene expression characteristics within each cluster (i.e. Fat-Residence Cluster refers to the gene cluster whose genes are expressed at greater levels in T cells residing in fat. Fat-Treg Cluster refers to the gene cluster whose genes are expressed highest in only the fTregs).
In vitro suppression assay
fTregs were isolated from aged wt mice treated with IL-2/anti-IL-2 complexes to expand fTreg numbers, as described above with isolation conducted on day 6. Stromal vascular fractions (SVFs) were isolated from visceral adipose tissues as described above, and fTregs were sorted from SVFs using the BD FACSAria instrument (Becton Dickinson), gating on CD45.2 + CD4 + CD25 + cells. CD45.1 + mice were sacrificed to isolate splenic responder T cells, which were purified by positive selection using CD4-specific Dynabeads (Invitrogen), followed by sorting on a BD FACSAria cell sorter, gating on CD45.1 + CD4 + CD25 − CD62L hi CD44 lo cells. Antigen-presenting cells were prepared from wild-type B6
splenocytes by T-cell depletion using Thy1-specific MACS beads. CFSE labeled effector T cells (5 ×10 4 cells well −1 ) were co-cultured with fTregs at the indicated ratio in the presence of irradiated (30 Gy) antigen-presenting cells (1 × 10 5 cells well −1 ) in 96-well plates in complete RPMI1640 medium supplemented with 10% FBS and CD3 antibody (1 μg ml −1 ). Cell proliferation and expansion index were determined 96h later using the BD FACSAria instrument and analyzed with the FlowJo software package (Tree Star).
ST2 studies and anti-ST2 depleting antibody treatment
Antibody for ST2 FACS analysis was purchased from MD Bioproducts, clone DJ8. For fTreg depletion, mice were injected i.p. with 200 μg anti-ST2 antibodies 36 (R&D systems, clone 245707) or isotype control (Bioxcell) twice (days 0, 2) and sacrificed for analysis on day 3.
Statistical analyses
Statistical analyses were performed with Prism 6.0 (GraphPad). p values were calculated using two-tailed unpaired or paired Student's t test. When analyzing adipo-immune profiles, we utilized a false discovery rate approach to avoid the problem of an inflated false-positive rate due to the substantial number of hypothesis tests. Mice cohort size was designed to be sufficient to enable statistical significance to be accurately determined. When applicable, mice were randomly assigned to treatment or control groups. No animals were excluded from the statistical analysis, with the exception of exclusions due to technical errors, and the investigators were not blinded in the studies. Appropriate statistical analyses were applied, assuming a normal sample distribution, as specified in the figure legends. No estimate of variance was made between each group. All in vivo metabolic and glucose homeostasis experiments, ex vivo glucose uptake experiments, and adipo-immune profiling experiments were conducted with at least two independent cohorts. RNA-Seq experiments, Luminex profiling, and histological analyses were conducted using multiple biological samples (as indicated in figure legends) from indicated cohorts. Weight-matched cohorts' body weights and adipocyte size frequency in VAT of aged control and fTreg KO mice. (a) Body weights of fTreg KO and control male mice used in weightmatched metabolic studies in young (12 week old; control n=9; fTreg KO n=9), aged (36 week old; control, n=9 mice; fTreg KO, n=11 mice), and obese (DIO, 12 weeks of HFD starting at 12 weeks old; control n=10; fTreg KO n=10) settings. (b) Frequency of small (0-5,000 μm 2 ), medium (5,000-10,000 μm 2 ), and large (>10,000 μm 2 ) adipocytes in VAT of aged control and fTreg KO mice (n=3 mice per group, 850 adipocytes counted from control mice, 269 adipocytes counted from fTreg KO adipose). Data represents mean ± s.e.m. Aged fTreg KO mice are resistant to short-term, but not persistent, HFD-induced weight gain and insulin resistance. (a-e) Aged control and fTreg KO mice were placed on HFD and monitored throughout course of diet for weight (a), fasting glucose levels (b), fasting serum insulin levels (c), performance on GTT (d), and ITT (e). (Control, n=10; fTreg KO, n=11; Mice were aged 27-29 weeks and weight-matched before HFD was introduced.) Data represents mean ± s.e.m. ns -non-significant, *p<0.05, **p<0.01. 
